Search by Drug Name or NDC
NDC 67386-0820-19 Northera 100 mg/1 Details
Northera 100 mg/1
Northera is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lundbeck Pharmaceuticals LLC. The primary component is DROXIDOPA.
MedlinePlus Drug Summary
Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.
Related Packages: 67386-0820-19Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Droxidopa
Product Information
NDC | 67386-0820 |
---|---|
Product ID | 67386-820_f720e062-fafd-49bf-ab8c-ab23b25e0545 |
Associated GPIs | 38700030000130 |
GCN Sequence Number | 072023 |
GCN Sequence Number Description | droxidopa CAPSULE 100 MG ORAL |
HIC3 | J5H |
HIC3 Description | ADRENERGIC VASOPRESSOR AGENTS |
GCN | 36088 |
HICL Sequence Number | 040936 |
HICL Sequence Number Description | DROXIDOPA |
Brand/Generic | Brand |
Proprietary Name | Northera |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | droxidopa |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/1 |
Substance Name | DROXIDOPA |
Labeler Name | Lundbeck Pharmaceuticals LLC |
Pharmaceutical Class | Catecholamines [CS], Increased Blood Pressure [PE] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA203202 |
Listing Certified Through | 2025-12-31 |
Package
NDC 67386-0820-19 (67386082019)
NDC Package Code | 67386-820-19 |
---|---|
Billing NDC | 67386082019 |
Package | 90 CAPSULE in 1 BOTTLE (67386-820-19) |
Marketing Start Date | 2014-09-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |